Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.
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
(TTXVN/Vietnam+)
-
2024-12-15 13:32:00
-
2024-12-15 13:30:00
-
2020-07-30 08:48:00